Craft

Kahr medical

Total Funding

$40 M

Kahr medical Summary

Company Summary

Overview
Kahr medical is a company that develops a novel drug platform designed to offer immuno-oncology therapies. Its platform uses the Dual Signaling Proteins (DSP) technology for the development of third-generation biological drugs having fusion-protein molecules for the treatment of multiple types of cancer, enabling doctors to manage the immune system and target complex biological processes within the immune system.
Type
Private
Status
Active
Founded
2005
HQ
Jerusalem, IL | view all locations
Website
https://kahrbio.com/
Cybersecurity rating
Sectors

Key People

LocationsView all

1 location detected

  • Jerusalem, Jerusalem District HQ

    Israel

Footer menu